€0.55
Your prediction
D.Western Therapeutics Institute Inc Stock
Pros and Cons of D.Western Therapeutics Institute Inc in the next few years
Pros
Cons
Performance of D.Western Therapeutics Institute Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| D.Western Therapeutics Institute Inc | 5.770% | 6.796% | -13.386% | -56.349% | -31.677% | -73.810% | -85.163% |
| Takara Bio Inc. | - | 0.877% | 6.481% | -48.661% | -25.325% | -72.619% | -70.145% |
| NanoCarrier Co Ltd | 1.300% | 5.405% | -39.535% | -43.478% | -33.898% | -64.220% | -76.007% |
| Shin Nippon Biomedical Laboratories Ltd. | 0.560% | 2.857% | 5.263% | -44.785% | -14.286% | 68.224% | 51.007% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon an initial overview of the financial statements of DWTI, a company within the Biotechnology & Medical Research industry, it appears that the company has experienced fluctuations in its financial position in recent years. The revenues have shown a consistent upward trend, while expenses have increased dramatically during the same period. This has led to changes in net income and cash flow, reflecting the company's dynamic growth.
Revenue Growth: The company's total revenue has increased consistently over the years, as indicated in the income statements. This is a positive sign of growth for the company.
Strong Research & Development Investment: In the competitive field of Biotechnology & Medical Research, continuous investment in R&D is crucial for staying ahead. DWTI has shown commitment in this regard as evident from the increasing research & development expenses over the years.